Expanding and Personalizing Treatment Options for Alcohol Use Disorders Including Pharmacogenomics
Published Date
Agency
CFDA
93.273
Contact Information
Raye Z. Litten, Ph.D., 301-443-0636; rlitten@mail.nih.gov
Deadline
Department
Eligiblity
State, local and tribal governments, institutions of higher education and tribal, nonprofit and for-profit organizations
More Information
Program Area
Programe Purpose
To study how genetic variation affects responses to medications for the treatment of alcohol use disorders
